Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have earned a consensus rating of “Moderate Buy” from the six brokerages that are currently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $30.83.

Several equities analysts have commented on the stock. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $38.00 to $27.00 in a research report on Monday, November 4th. JMP Securities increased their price target on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a report on Monday, September 30th. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. Truist Financial lowered their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Finally, Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their target price for the company from $38.00 to $26.00 in a research report on Thursday, October 31st.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the stock in a transaction dated Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. Janus Henderson Group PLC increased its position in shares of Option Care Health by 182.9% during the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock worth $7,617,000 after acquiring an additional 146,837 shares during the period. Tidal Investments LLC grew its stake in Option Care Health by 74.2% in the first quarter. Tidal Investments LLC now owns 13,460 shares of the company’s stock worth $451,000 after purchasing an additional 5,733 shares in the last quarter. Harbor Capital Advisors Inc. grew its stake in Option Care Health by 317.9% in the second quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock worth $2,670,000 after purchasing an additional 73,312 shares in the last quarter. SG Americas Securities LLC increased its holdings in Option Care Health by 619.3% during the 2nd quarter. SG Americas Securities LLC now owns 60,356 shares of the company’s stock worth $1,672,000 after purchasing an additional 51,965 shares during the period. Finally, Blue Trust Inc. raised its position in Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after purchasing an additional 377 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Up 0.1 %

NASDAQ OPCH opened at $23.76 on Friday. The stock has a 50 day moving average price of $27.00 and a 200-day moving average price of $28.93. Option Care Health has a one year low of $21.39 and a one year high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market capitalization of $4.04 billion, a P/E ratio of 19.97, a P/E/G ratio of 2.42 and a beta of 1.32.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.